France has developed an artificial heart that could potentially transform treatment for people with severe heart failure. 🫀🇫🇷 The device, called Aeson, was developed by French medical technology company CARMAT. It is designed as a fully implantable artificial heart capable of replacing the function of both sides of a failing human heart. What makes the technology particularly interesting is its ability to adjust blood flow based on the patient’s activity. When the person is resting, the device can reduce its output. During physical activity, it can increase blood flow to meet the body’s greater demands. 🚶‍♂️❤️ Currently, Aeson is primarily used as a bridge to transplantation, helping some patients stay alive while they wait for a suitable donor heart. However, the long-term vision is much more ambitious. Researchers hope artificial hearts can eventually allow patients to live without requiring a donor transplant. If that becomes possible, it could dramatically change the future of heart failure treatment. Instead of spending months waiting for a matching donor, patients could potentially receive an engineered replacement designed to support their circulation continuously. The technology is not yet a permanent replacement for every patient, and significant challenges remain. Still, artificial-heart research represents an important step toward a future where a failing heart may no longer automatically mean waiting for another human heart. 🫀🔬✨